Drug Type Therapeutic vaccine |
Synonyms Purethal Mites, Purethal |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date DE (01 Jan 2011), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Conjunctivitis, Allergic | DE | 01 Jan 2011 | |
Rhinitis, Allergic | DE | 01 Jan 2011 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
House dust mite allergy | Phase 2 | DE | 01 Sep 2011 | |
House dust mite allergy | Phase 2 | BE | 01 Sep 2011 | |
House dust mite allergy | Phase 2 | NL | 01 Sep 2011 | |
House dust mite allergy | Phase 2 | AT | 01 Sep 2011 | |
House dust mite allergy | Phase 2 | ES | 01 Sep 2011 | |
Rhinitis, Allergic | Phase 2 | NL | 01 Sep 2011 | |
Rhinitis, Allergic | Phase 2 | AT | 01 Sep 2011 | |
Rhinitis, Allergic | Phase 2 | BE | 01 Sep 2011 | |
Rhinitis, Allergic | Phase 2 | ES | 01 Sep 2011 | |
Rhinoconjunctivitis | Phase 2 | NL | 01 Sep 2011 |